Tuesday, May 20, 2014

Edwards LifeScience, Medtronic Settle Patent Dispute

Earlier today Edwards LifeScience and Medtronic agreed to a global settlement of the litigation over Edwards' transcatheter heart valve technology.  Medtronic will pay $750 million upfront, with ongoing royalties through April 2022.  Wall Street Journal story here, Forbes here, Reuters here.  This should be the end of the litigation I reported on last month here and here.

No comments:

Post a Comment